Drug factory · FDA FEI 3003382089
Upjohn Manufacturing Ireland Unlimited Company
Little Island, Cork, Ireland
Problems found, fixed voluntarily at FDA's last inspection, Jan 26, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2011: 1 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Axitinib | Makes the active ingredient and tests it | Pfizer Laboratories Div Pfizer Inc | 0069-0145, 0069-0151 |
| Crizotinib | Makes the active ingredient and tests it | Pfizer Laboratories Div Pfizer Inc | 0069-0251, 0069-0507, 0069-1500 +2 |
| Voriconazole | Makes the active ingredient | Mylan Pharmaceuticals Inc., Roerig | 59762-0935, 0049-3160, 0049-3170 +3 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 26, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 2, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 31, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 25, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Apr 11, 2014 | No problems found | Drug Quality Assurance | — |
| Jun 17, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.